首页|中医药干预mTOR通路靶向自噬防治糖尿病肾病的研究现状

中医药干预mTOR通路靶向自噬防治糖尿病肾病的研究现状

Research status of traditional Chinese medicine intervention in mTOR pathway targeting autophagy for prevention and treatment of diabetic nephropathy

扫码查看
原文链接
  • 国家科技期刊平台
  • NETL
  • NSTL
  • 万方数据
糖尿病肾病(DKD)是糖尿病最重要的并发症之一.近年来,国内外研究发现,哺乳动物西罗莫司靶蛋白(mTOR)相关信号通路是参与自噬调节的一个经典通路,可通过靶向自噬途径达到治疗DKD的效果,在防治DKD中发挥着至关重要的作用.本文将主要从中医药干预mTOR相关信号通路靶向自噬防治DKD的作用机制做一综述,以期为临床防治DKD提供新的参考及依据.
Diabetic kidney disease(DKD)is one of the most important complications of diabetes.In recent years,domestic and foreign studies have found that mammalian target protein of rapamycin(mTOR)related signaling pathway is a classic pathway involved in the regulation of autophagy,which can achieve the therapeutic effect of DKD by targeting the autophagy pathway,and plays a crucial role in the prevention and treatment of DKD.In this paper,we reviewed the mechanism of mTOR-related signaling pathway targeted autophagy in the prevention and treatment of DKD,in order to provide a new reference and basis for clinical prevention and treatment of DKD.

phosphoinositol 3 kinase/protein kinase B/mammalian rapamycin target pathwayadenosine monophosphate-activated protein kinase/mammalian target of rapamycin signaling pathwayautophagydiabetic kidney

杨世睿、周婷婷、马超超、杨鹏斐、牛凡琪、杜雪洋、闫丰喆、王思农

展开 >

甘肃中医药大学中医临床学院,甘肃兰州 730000

磷酸肌醇-3-激酶/蛋白激酶B/哺乳动物西罗莫司靶蛋白信号通路 腺苷酸活化蛋白激酶/哺乳动物西罗莫司靶蛋白信号通路 自噬 糖尿病肾病

甘肃省教育厅产业支撑计划

2021CYZC-03

2024

10.13699/j.cnki.1001-6821.2024.11.029

中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCD北大核心
影响因子：1.91
ISSN：1001-6821
年,卷(期)：2024.40(11)
  • 23